The extended cleavage specificity of human thrombin

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Gallwitz, Maike ^a   Enoksson, Mattias ^a,b   Thorpe, Michael ^a   Hellman, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 1; AGOUTI RELATED PROTEIN; ASPARTIC ACID; ATRIAL NATRIURETIC FACTOR; CARDIOTROPHIN 1; CD51 ANTIGEN; CHORDIN; COLLAGEN 1ALPHA I; COLLAGEN 1ALPHA III; COLLAGEN 1ALPHA V; COLLAGEN 1ALPHA XI; DYSTROGLYCAN; ENDOTHELIN 1; FIBROMODULIN; FOLATE RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; INTEGRIN ALPHAD; INTEGRIN ALPHAE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MATRIX METALLOPROTEINASE 25; MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE W; NIDOGEN 2; NOTCH3 RECEPTOR; PHOSPHOLIPASE A2; THIOREDOXIN; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE INSERTION; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RESTRICTION SITE; SEQUENCE ALIGNMENT; SYNAPTIC TRANSMISSION; BINDING SITE; BIOLOGY; CHEMISTRY; ESCHERICHIA COLI; GENETICS; KINETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PEPTIDE LIBRARY; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BINDING SITES; COMPUTATIONAL BIOLOGY; ESCHERICHIA COLI; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY; THIOREDOXINS; THROMBIN;

EID: 84857598530     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031756     Document Type: Article

References (62)

1. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C, (2003) Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4: 544-558.
2. Kraut J, (1977) Serine proteases: structure and mechanism of catalysis. Annu Rev Biochem 46: 331-358.
3. Southan C, (2001) A genomic perspective on human proteases as drug targets. Drug Discov Today 6: 681-688.
4. Davie EW, Kulman JD, (2006) An overview of the structure and function of thrombin. Semin Thromb Hemost 32 (Suppl 1): 3-15.
5. Coughlin SR, (2000) Thrombin signalling and protease-activated receptors. Nature 407: 258-264.
6. Huntington JA, (2005) Molecular recognition mechanisms of thrombin. J Thromb Haemost 3: 1861-1872.
7. Pozsgay M, Szabo G, Bajusz S, Simonsson R, Gaspar R, et al. (1981) Study of the specificity of thrombin with tripeptidyl-p-nitroanilide substrates. Eur J Biochem 115: 491-495.
8. Lottenberg R, Hall JA, Blinder M, Binder EP, Jackson CM, (1983) The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. Biochim Biophys Acta 742: 539-557.
9. Schechter I, Berger A, (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27: 157-162.
10. Diamond SL, (2007) Methods for mapping protease specificity. Curr Opin Chem Biol 11: 46-51.
11. Kawabata S, Miura T, Morita T, Kato H, Fujikawa K, et al. (1988) Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin. Eur J Biochem 172: 17-25.
12. Chang JY, (1985) Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate. Eur J Biochem 151: 217-224.
13. Le Bonniec BF, MacGillivray RT, Esmon CT, (1991) Thrombin Glu-39 restricts the P′3 specificity to nonacidic residues. J Biol Chem 266: 13796-13803.
14. Petrassi HM, Williams JA, Li J, Tumanut C, Ek J, et al. (2005) A strategy to profile prime and non-prime proteolytic substrate specificity. Bioorg Med Chem Lett 15: 3162-3166.
15. Backes BJ, Harris JL, Leonetti F, Craik CS, Ellman JA, (2000) Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat Biotechnol 18: 187-193.
16. Stephens AW, Siddiqui A, Hirs CH, (1988) Site-directed mutagenesis of the reactive center (serine 394) of antithrombin III. J Biol Chem 263: 15849-15852.
17. Theunissen HJ, Dijkema R, Grootenhuis PD, Swinkels JC, de Poorter TL, et al. (1993) Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site. J Biol Chem 268: 9035-9040.
18. Le Bonniec BF, Myles T, Johnson T, Knight CG, Tapparelli C, et al. (1996) Characterization of the P2′ and P3′ specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. Biochemistry 35: 7114-7122.
19. Marque PE, Spuntarelli R, Juliano L, Aiach M, Le Bonniec BF, (2000) The role of Glu(192) in the allosteric control of the S(2)′ and S(3)′ subsites of thrombin. J Biol Chem 275: 809-816.
20. Ebert RF, (1991) Index of Variant Human Fibrinogen Boca Raton, Florida CRC Press.
21. Karlson U, Pejler G, Froman G, Hellman L, (2002) Rat mast cell protease 4 is a beta-chymase with unusually stringent substrate recognition profile. J Biol Chem 277: 18579-18585.
22. Gallwitz M, Enoksson M, Hellman L, (2007) Expression profile of novel members of the rat mast cell protease (rMCP)-2 and (rMCP)-8 families, and functional analyses of mouse mast cell protease (mMCP)-8. Immunogenetics 59: 391-405.
23. Harris JL, Peterson EP, Hudig D, Thornberry NA, Craik CS, (1998) Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem 273: 27364-27373.
24. Hills R, Mazzarella R, Fok K, Liu M, Nemirovskiy O, et al. (2007) Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate. J Biol Chem 282: 11101-11109.
25. McCarter JD, Stephens D, Shoemaker K, Rosenberg S, Kirsch JF, et al. (2004) Substrate specificity of the Escherichia coli outer membrane protease OmpT. J Bacteriol 186: 5919-5925.
26. Cloutier SM, Chagas JR, Mach JP, Gygi CM, Leisinger HJ, et al. (2002) Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology. Eur J Biochem 269: 2747-2754.
27. Andersson MK, Pemberton AD, Miller HR, Hellman L, (2008) Extended cleavage specificity of mMCP-1, the major mucosal mast cell protease in mouse-high specificity indicates high substrate selectivity. Mol Immunol 45: 2548-2558.
28. Andersson MK, Karlson U, Hellman L, (2008) The extended cleavage specificity of the rodent beta-chymases rMCP-1 and mMCP-4 reveal major functional similarities to the human mast cell chymase. Mol Immunol 45: 766-775.
29. Andersson MK, Enoksson M, Gallwitz M, Hellman L, (2009) The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile. Int Immunol 21: 95-104.
30. Gallwitz M, Enoksson M, Thorpe M, Ge X, Hellman L, (2010) The extended substrate recognition profile of the dog mast cell chymase reveals similarities and differences to the human chymase. Int Immunol 22: 421-431.
31. Reimer JM, Enoksson M, Samollow PB, Hellman L, (2008) Extended substrate specificity of opossum chymase-implications for the origin of mast cell chymases. Mol Immunol 45: 2116-2125.
32. Pan W, Arnone M, Kendall M, Grafstrom RH, Seitz SP, et al. (2003) Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display. J Biol Chem 278: 27820-27827.
33. Karlson U, Pejler G, Tomasini-Johansson B, Hellman L, (2003) Extended substrate specificity of rat mast cell protease 5, a rodent alpha-chymase with elastase-like primary specificity. J Biol Chem 278: 39625-39631.
34. Karlson U, (2003) Cutting Edge- Cleavage Specificity and Biochemical Characterization of Mast Cell Serine Proteases [dissertation] Uppsala Uppsala University.
35. Scheraga HA, Ehrenpreis S, Sullivan E, (1958) Comparative kinetic behaviour of thrombin, plasmin and trypsin toward synthetic substrates. Nature 182: 461-462.
36. Chang JY, Alkan SS, Hilschmann N, Braun DG, (1985) Thrombin specificity. Selective cleavage of antibody light chains at the joints of variable with joining regions and joining with constant regions. Eur J Biochem 151: 225-230.
37. Vindigni A, Dang QD, Di Cera E, (1997) Site-specific dissection of substrate recognition by thrombin. Nat Biotechnol 15: 891-895.
38. Muszbek L, Laki K, (1984) The Thrombin; In: Machovic R, editors. Boca Raton, Florida CRC Press Inc pp. 83-102.
39. Ng NM, Quinsey NS, Matthews AY, Kaiserman D, Wijeyewickrema LC, et al. (2009) The effects of exosite occupancy on the substrate specificity of thrombin. Arch Biochem Biophys 489: 48-54.
40. Bianchini EP, Louvain VB, Marque PE, Juliano MA, Juliano L, et al. (2002) Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substrates. J Biol Chem 277: 20527-20534.
41. Ovaere P, Lippens S, Vandenabeele P, Declercq W, (2009) The emerging roles of serine protease cascades in the epidermis. Trends Biochem Sci 34: 453-463.
42. Hachem JP, Man MQ, Crumrine D, Uchida Y, Brown BE, et al. (2005) Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 125: 510-520.
43. Lane DA, Philippou H, Huntington JA, (2005) Directing thrombin. Blood 106: 2605-2612.
44. Bock PE, Panizzi P, Verhamme IM, (2007) Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost 5 (Suppl 1): 81-94.
45. Chang GT, Aaldering L, Hackeng TM, Reitsma PH, Bertina RM, et al. (1994) Construction and characterization of thrombin-resistant variants of recombinant human protein S. Thromb Haemost 72: 693-697.
46. Boffa MB, Bell R, Stevens WK, Nesheim ME, (2000) Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor. J Biol Chem 275: 12868-12878.
47. Andersson MK, Thorpe M, Hellman L, (2010) Arg143 and Lys192 of the human mast cell chymase mediate the preference for acidic amino acids in position P2′ of substrates. Febs J 277: 2255-2267.
48. Mayer U, Mann K, Timpl R, Murphy G, (1993) Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling. Eur J Biochem 217: 877-884.
49. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, et al. (1981) Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636.
50. Sigle RO, Gil SG, Bhattacharya M, Ryan MC, Yang TM, et al. (2004) Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. J Cell Sci 117: 4481-4494.
51. de La Houssaye BA, Mikule K, Nikolic D, Pfenninger KH, (1999) Thrombin-induced growth cone collapse: involvement of phospholipase A(2) and eicosanoid generation. J Neurosci 19: 10843-10855.
52. de Castro Ribeiro M, Badaut J, Price M, Meins M, Bogousslavsky J, et al. (2006) Thrombin in ischemic neuronal death. Exp Neurol 198: 199-203.
53. Ramos-Mandujano G, Vazquez-Juarez E, Hernandez-Benitez R, Pasantes-Morales H, (2007) Thrombin potently enhances swelling-sensitive glutamate efflux from cultured astrocytes. Glia 55: 917-925.
54. Ohnishi M, Katsuki H, Fujimoto S, Takagi M, Kume T, et al. (2007) Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury. Exp Neurol 206: 43-52.
55. Xi G, Reiser G, Keep RF, (2003) The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem 84: 3-9.
56. Gingrich MB, Junge CE, Lyuboslavsky P, Traynelis SF, (2000) Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20: 4582-4595.
57. Hawkins RL, Seeds NW, (1989) Protease inhibitors influence the direction of neurite outgrowth. Brain Res Dev Brain Res 45: 203-209.
58. Junge CE, Sugawara T, Mannaioni G, Alagarsamy S, Conn PJ, et al. (2003) The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci U S A 100: 13019-13024.
59. Fang M, Kovacs KJ, Fisher LL, Larson AA, (2003) Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. J Physiol 549: 903-917.
60. Faraut B, Barbier J, Ravel-Chapuis A, Doyennette MA, Jandrot-Perrus M, et al. (2003) Thrombin downregulates muscle acetylcholine receptors via an IP3 signaling pathway by activating its G-protein-coupled protease-activated receptor-1. J Cell Physiol 196: 105-112.
61. Wells CM, Di Cera E, (1992) Thrombin is a Na(+)-activated enzyme. Biochemistry 31: 11721-11730.
62. Neuhoff V, Arold N, Taube D, Ehrhardt W, (1988) Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9: 255-262.